{"id":"scopolamine-patch","safety":{"commonSideEffects":[{"rate":"30-50","effect":"Dry mouth"},{"rate":"15-30","effect":"Drowsiness"},{"rate":"5-15","effect":"Blurred vision"},{"rate":"5-10","effect":"Dizziness"},{"rate":"5-10","effect":"Mydriasis (dilated pupils)"}]},"_chembl":{"chemblId":"CHEMBL2251240","moleculeType":"Small molecule","molecularWeight":"438.32"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Scopolamine is an anticholinergic agent that antagonizes muscarinic acetylcholine receptors, particularly in the chemoreceptor trigger zone and vestibular nuclei of the brain. By inhibiting these receptors, it suppresses signals that trigger the vomiting reflex and reduces motion-induced nausea. The transdermal patch formulation provides sustained drug delivery over several days.","oneSentence":"Scopolamine blocks muscarinic acetylcholine receptors in the central nervous system to prevent nausea and vomiting.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:07:07.181Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of nausea and vomiting associated with motion sickness"},{"name":"Prevention of postoperative nausea and vomiting"}]},"trialDetails":[{"nctId":"NCT03616067","phase":"PHASE3","title":"Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy","status":"TERMINATED","sponsor":"Hospices Civils de Lyon","startDate":"2022-04-27","conditions":"Cerebral Palsy","enrollment":23},{"nctId":"NCT04993508","phase":"NA","title":"Randomized Prospective Multi Center Cohort Study for Primary Diagnosis of Clinically Significant Prostate Cancer With Combination of PSA/DRE and Multi Parametric Magnetic Resonance Imaging","status":"NOT_YET_RECRUITING","sponsor":"Heinrich-Heine University, Duesseldorf","startDate":"2026-04-01","conditions":"Prostate Cancer","enrollment":1908},{"nctId":"NCT04240626","phase":"PHASE4","title":"Multimodal Analgesia Effect on Post Surgical Patient","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Davis","startDate":"2021-01-20","conditions":"Obesity, Morbid, Surgery, Bariatric Surgery Candidate","enrollment":60},{"nctId":"NCT04366518","phase":"EARLY_PHASE1","title":"Toward a Computationally-Informed, Personalized Treatment for Hallucinations","status":"RECRUITING","sponsor":"Yale University","startDate":"2021-07-15","conditions":"Hallucinations, Auditory, Psychosis","enrollment":35},{"nctId":"NCT05260320","phase":"NA","title":"Anesthetic Optimization in Pediatric LeFort Surgeries","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-05-02","conditions":"Le Fort, Pain, Postoperative","enrollment":50},{"nctId":"NCT04081545","phase":"PHASE3","title":"Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery","status":"COMPLETED","sponsor":"Christine Oryhan","startDate":"2019-12-24","conditions":"Opioid Use, Unspecified, Bariatric Surgery Candidate, Anesthesia","enrollment":181},{"nctId":"NCT05021263","phase":"PHASE3","title":"Does IV Magnesium Improve Quality of Recovery With ERAS Protocols in Laparoscopic Colorectal Surgery?","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2022-05-27","conditions":"Colo-rectal Cancer, Anesthesia","enrollment":90},{"nctId":"NCT03435003","phase":"PHASE4","title":"Designing Optimal Prevention and Management of Postoperative Nausea and Emesis for Patients Undergoing Laparoscopic Sleeve Gastrectomy","status":"COMPLETED","sponsor":"Stony Brook University","startDate":"2017-08-28","conditions":"Post-operative Nausea and Vomiting, Laparoscopic Sleeve Gastrectomy","enrollment":83},{"nctId":"NCT02849639","phase":"EARLY_PHASE1","title":"The INCREASE Study - Delaying the Onset of Alzheimer's Symptomatic Expression","status":"COMPLETED","sponsor":"Daniela Moga","startDate":"2017-04-04","conditions":"Alzheimer's Disease, Dementia","enrollment":90},{"nctId":"NCT02960113","phase":"PHASE4","title":"Scopolamine Patch and Acupressure Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean Section","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2016-05","conditions":"Nausea, Vomiting, Satisfaction","enrollment":240},{"nctId":"NCT04008264","phase":"","title":"A Novel Usage of Transdermal Scopolamine in Reducing Narcotic Usage in Outpatient Hand Surgery","status":"COMPLETED","sponsor":"Alexander M Spiess, MD","startDate":"2019-06-25","conditions":"Post Operative Pain Management","enrollment":74},{"nctId":"NCT04272255","phase":"PHASE3","title":"Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness","status":"UNKNOWN","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2019-04-22","conditions":"Motion Sickness","enrollment":300},{"nctId":"NCT03986905","phase":"PHASE3","title":"The Prevention and Treatment of Nausea Associated With Motion Sickness","status":"COMPLETED","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2019-04-26","conditions":"Motion Sickness","enrollment":300},{"nctId":"NCT04184115","phase":"PHASE3","title":"Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness","status":"COMPLETED","sponsor":"Repurposed Therapeutics, Inc.","startDate":"2019-06-09","conditions":"Motion Sickness","enrollment":102},{"nctId":"NCT03920644","phase":"PHASE3","title":"Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels","status":"UNKNOWN","sponsor":"Naval Aeromedical Research Unit, Dayton","startDate":"2019-04","conditions":"Prevention of Nausea Associated With Motion Sickness, Treatment of Nausea Associated With Motion Sickness","enrollment":320},{"nctId":"NCT03029650","phase":"PHASE4","title":"Scopolamine Patch Pharmacokinetics in Healthy Adults","status":"COMPLETED","sponsor":"University of Iowa","startDate":"2016-11","conditions":"Healthy","enrollment":26},{"nctId":"NCT02839135","phase":"PHASE1","title":"A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants.","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-05-13","conditions":"Motion Sickness","enrollment":128},{"nctId":"NCT02968082","phase":"PHASE4","title":"The Effects of Preoperative Scopolamine Patch Application on the Postoperative Nausea and Vomiting in MVD Surgery","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-11","conditions":"Patients","enrollment":60},{"nctId":"NCT02725398","phase":"NA","title":"Effect of Buscopan on Gastrointestinal Imaging Quality With Probe-based Confocal Laser Endomicroscopy","status":"UNKNOWN","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2013-12","conditions":"Gastrointestinal Imaging With pCLE","enrollment":150},{"nctId":"NCT02410460","phase":"NA","title":"Anesthetics in Rhytidoplasty - A Comparison Study","status":"COMPLETED","sponsor":"Mercy Facial Plastic Surgery Center","startDate":"2013-09","conditions":"Rhytidoplasty","enrollment":30},{"nctId":"NCT01592708","phase":"NA","title":"Study of Anesthesia Techniques to Reduce Nausea and Vomiting After Jaw Corrective Surgery","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2012-06","conditions":"Post-operative Nausea, Post-operative Vomiting, Nausea Persistent","enrollment":233},{"nctId":"NCT00659737","phase":"NA","title":"Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting","status":"COMPLETED","sponsor":"Drexel University College of Medicine","startDate":"2008-04","conditions":"Nausea, Vomiting","enrollment":115},{"nctId":"NCT01465906","phase":"PHASE4","title":"Efficacy and Safety of Tulobuterol Patch Combined With Tiotropium Bromide for Relieving Dyspnea Symptom of Chronic Obstructive Pulmonary Disease","status":"UNKNOWN","sponsor":"Shanghai Zhongshan Hospital","startDate":"2010-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":160},{"nctId":"NCT01399710","phase":"PHASE3","title":"Impact of Computer-Aided Detection (CAD) as Second Reader in CT Colonography","status":"COMPLETED","sponsor":"im3D S.p.A.","startDate":"2007-07","conditions":"Individuals With Suspected Colorectal Disease","enrollment":651}],"_emaApprovals":[],"_faersSignals":[{"count":19,"reaction":"NAUSEA"},{"count":16,"reaction":"VOMITING"},{"count":11,"reaction":"DIZZINESS"},{"count":9,"reaction":"HEADACHE"},{"count":7,"reaction":"DEHYDRATION"},{"count":6,"reaction":"FATIGUE"},{"count":5,"reaction":"DEATH"},{"count":5,"reaction":"FEELING ABNORMAL"},{"count":4,"reaction":"ANXIETY"},{"count":4,"reaction":"CONFUSIONAL STATE"}],"_approvalHistory":[],"publicationCount":82,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Transderm-Scop","Scopace","Maldemar","Scopolamine","Scopolamine Challenge"],"phase":"marketed","status":"active","brandName":"scopolamine patch","genericName":"scopolamine patch","companyName":"Rutgers, The State University of New Jersey","companyId":"rutgers-the-state-university-of-new-jersey","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Scopolamine blocks muscarinic acetylcholine receptors in the central nervous system to prevent nausea and vomiting. Used for Prevention of nausea and vomiting associated with motion sickness, Prevention of postoperative nausea and vomiting.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}